During the past decade, Imperial Health conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Imperial Health" #1 sponsor was "Pfizer" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Integra LifeSciences Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Imperial Health" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Imperial Health" are "Acute Coronary Syndromes" (1 trials), "Arthroplasty, Replacement, Knee" (1 trials), "Cardiovascular Disease" (1 trials), "Chronic Venous Disorder" (1 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "Imperial Health" in a lesser frequency.

Most popular intervention types in "Imperial Health" are "Device" (4 trials), "Drug" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Acetylsalicylic acid" (1 trials), "Acetylsalicylic acid placebo" (1 trials), "Apixaban" (1 trials) and "Bococizumab (PF-04950615; RN316)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Imperial Health" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Imperial Health". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Imperial Health, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Imperial Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".